AUS
NZ
UK
CA
USA
IND
Headlines
- Arkadios Wealth Advisors acquires 2,050 shares of Cardinal Health.
- Analysts upgrade ratings and increase target prices for Cardinal Health.
- Cardinal Health achieves significant EPS growth, exceeding market expectations.
Cardinal Health, Inc. (NYSE:CAH) has recently garnered substantial attention from institutional investors and market analysts alike. Arkadios Wealth Advisors, in particular, acquired a sizeable position of 2,050 shares in Cardinal Health during the fourth quarter, signaling confidence from large investors. This acquisition signifies a movement among other large investors such as Eastern Bank and Carolina Wealth Advisors, further solidifying Cardinal Health's standing in the investment community.
As of their latest quarterly earnings on November 1st, Cardinal Health reported earnings per share (EPS) of $1.88, surpassing analyst expectations of $1.62. This performance showcases both resilience and growth, despite a slight dip in revenue from the previous year. With a robust market capitalization and strategic initiatives in different geographies, Cardinal Health places itself as a leading player in healthcare services and products industry. With the EPS forecast set at 7.82 for the current year, continued growth is anticipated.
Additionally, Cardinal Health has declared a quarterly dividend, reflecting a dividend payout ratio of 39.30%. This initiative further amplifies the company’s market strength and commitment to enhancing shareholder value. The dividend was dispensed on January 15th, following the record date of January 2nd, amounting to an annualized yield of 1.56%.
In summary, Cardinal Health is set on a positive trajectory supported by institutional investments and positive analyst ratings, indicating investor confidence and promising growth outlooks. As the company continues to expand globally with its customized healthcare solutions, it remains a noteworthy entity in the healthcare sector.
